# Estrella Immunopharma, Inc.: Form 10-KT, filed Mar 25, 2025

- Company: [Estrella Immunopharma, Inc.](/companies/esla.md) (CIK 1844417)
- Form: 10-KT
- Filed: 2025-03-25
- Accepted by EDGAR: Mar 25, 2025, 16:30 ET
- Period: 2024-12-31
- Accession: 0001013762-25-002190
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1844417/000101376225002190/ea0229982-10kt_estrella.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1844417/000101376225002190/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 6 months, 2024-07-01 to 2024-12-31 | $2.9m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 6 months, 2024-07-01 to 2024-12-31 | −$4.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 6 months, 2024-07-01 to 2024-12-31 | $63 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 6 months, 2024-07-01 to 2024-12-31 | −$4.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 6 months, 2024-07-01 to 2024-12-31 | −$0.12 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 6 months, 2024-07-01 to 2024-12-31 | −$0.12 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 6 months, 2024-07-01 to 2024-12-31 | 36,515,688 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2024-07-01 to 2024-12-31 | −$3.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2024-12-31 | $916.9k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2024-12-31 | $1.6m | us-gaap:AssetsCurrent |
| Total assets | at 2024-12-31 | $3.1m | us-gaap:Assets |
| Current liabilities | at 2024-12-31 | $3.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2024-12-31 | $3.0m | us-gaap:Liabilities |
| Shareholders' equity | at 2024-12-31 | $143.7k | us-gaap:StockholdersEquity |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1844417/000101376225002190/ea0229982-10kt_estrella.htm

Filed Mar 25, 2025.
Source: SEC EDGAR, the filing index for accession 0001013762-25-002190. Last ingested by Listed: Nov 4, 2026, 07:37 ET. No prices; not investment advice.